Tarsus Pharmaceuticals takes in $60 mln Series B
Irvine, California-based Tarsus Pharmaceuticals, a clinical-stage biopharmaceutical company, has secured $60 million in Series B financing.
Irvine, California-based Tarsus Pharmaceuticals, a clinical-stage biopharmaceutical company, has secured $60 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination